Beranda › Obesitas › North Carolina › Wilmington
Uji klinis Obesitas di Wilmington, NC
15 studi untuk Obesitas mencari peserta di lokasi sekitar Wilmington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Menerima pesertaFase 2
- Accellacare - Tradd Court - Wilmington /ID# 282200, Wilmington
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Menerima pesertaFase 2
- TMA Headlands, Wilmington
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Menerima pesertaFase 3
- Accellacare and KDCILM, LLC, Wilmington
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Menerima pesertaFase 3
- Accellacare - Wilmington, Wilmington
- Jeffrey Coleman, OD, Wilmington
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Menerima pesertaFase 3
- Accellacare and KDCILM, LLC, Wilmington
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Menerima pesertaFase 3
- Trial Management Associates - Wilmington - Floral Parkway, Wilmington
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Menerima pesertaFase 3
- Accellacare - Wilmington - 1917 Tradd Court, Wilmington
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Menerima pesertaFase 3
- Accellacare of Wilmington, Wilmington
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Menerima pesertaFase 3
- KDCILM, LLC & Accellacare US, Inc., Wilmington
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Menerima pesertaFase 3
- Accellacare Research of Wilmington, Wilmington
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Menerima pesertaFase 3
- Accellacare Wilmington, Wilmington
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Menerima pesertaFase 3
- ACCOMPLISH-1 Research Site, Wilmington
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Menerima pesertaFase 2
- Accellacare of Wilmington, Wilmington
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Menerima pesertaFase 3
- Accellacare and KDCILM, LLC, Wilmington
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Menerima pesertaFase 1
- Accellacare, Wilmington
Uji klinis Obesitas di kota lain
- Houston, TX43 studi
- Chicago, IL41 studi
- New York City, NY40 studi
- San Antonio, TX40 studi
- Washington, DC33 studi
- Orlando, FL31 studi
- Dallas, TX30 studi
- Boston, MA28 studi
- Las Vegas, NV27 studi
- Miami, FL27 studi
- Baltimore, MD25 studi
- Jacksonville, FL25 studi
Studi lain di Wilmington
- Kelebihan Berat Badan11 studi
- Diabetes Tipe 28 studi
- Gagal Jantung6 studi
- Kolitis Ulseratif4 studi
- Tekanan Darah Tinggi3 studi
- Penyakit Kardiovaskular3 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.